Memorial Sloan-Kettering Cancer Center, N.Y., to price $450 million revenue bonds

By Cristal Cody

Springdale, Ark., April 8 - The Memorial Sloan-Kettering Cancer Center plans to price $450 million of revenue bonds on April 14, according to information released to Prospect News.

The $162.575 million series 2008A1 and $287.425 million series 2008A2 bonds will price through the Dormitory Authority of the State of New York.

Goldman, Sachs & Co. will be the senior manager for the negotiated sale of the bonds (Aa2/AA/AA).

Co-managers are Citi, UBS Investment Bank, J.P. Morgan Securities Inc., Lehman Brothers, Loop Capital Markets, Merrill Lynch & Co., Morgan Stanley, MR Beal & Co. and Sterne, Agree & Leach Inc.

Proceeds will be used to refund the cancer center's series 2002A revenue bonds.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.